Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model AnalysisDrug design, development and therapy, 2020-01, Vol.14, p.157-165 [Peer Reviewed Journal]2020 Yang et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Yang et al. 2020 Yang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s213968 ;PMID: 32021100Full text available |
|
2 |
Material Type: Article
|
Therapeutic Effects and Safe Uses of Plant-Derived Polyphenolic Compounds in Cardiovascular Diseases: A ReviewDrug design, development and therapy, 2021-01, Vol.15, p.4713-4732 [Peer Reviewed Journal]2021 Alotaibi et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Alotaibi et al. 2021 Alotaibi et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S327238 ;PMID: 34848944Full text available |
|
3 |
Material Type: Article
|
Evaluation of the cardiovascular effects of varenicline in ratsDrug design, development and therapy, 2015-01, Vol.9 (default), p.5705-5717 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Selçuk et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S92268 ;PMID: 26543352Full text available |
|
4 |
Material Type: Article
|
Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complicationsDrug design, development and therapy, 2015-01, Vol.9 (default), p.4735-4749 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Huri et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S87294 ;PMID: 26316711Full text available |
|
5 |
Material Type: Article
|
Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailabilityDrug design, development and therapy, 2017-01, Vol.11, p.811-826 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Dennison et al. This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License 2017 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S126035 ;PMID: 28352156Full text available |
|
6 |
Material Type: Article
|
SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic CardiomyopathyDrug design, development and therapy, 2020-01, Vol.14, p.4775-4788 [Peer Reviewed Journal]COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Li and Zhou. 2020 Li and Zhou. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S269514 ;PMID: 33192053Full text available |
|
7 |
Material Type: Article
|
Chemical Chaperones to Inhibit Endoplasmic Reticulum Stress: Implications in DiseasesDrug design, development and therapy, 2022-01, Vol.16, p.4385-4397 [Peer Reviewed Journal]2022 Jeon et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Jeon et al. 2022 Jeon et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S393816 ;PMID: 36583112Full text available |
|
8 |
Material Type: Article
|
Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory ResponseDrug design, development and therapy, 2019-11, Vol.13, p.3899-3911 [Peer Reviewed Journal]2019 Ding et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Ding et al. 2019 Ding et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S207185 ;PMID: 31819365Full text available |
|
9 |
Material Type: Article
|
Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current InsightsDrug design, development and therapy, 2022-01, Vol.16, p.2177-2186 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Chilbert et al. 2022 Chilbert et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S332352 ;PMID: 35832642Full text available |
|
10 |
Material Type: Article
|
Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to Induce Autophagy and Inhibit AtherosclerosisDrug design, development and therapy, 2020-02, Vol.14, p.457-468 [Peer Reviewed Journal]2020 You et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 You et al. 2020 You et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s233932 ;PMID: 32099330Full text available |
|
11 |
Material Type: Article
|
Liraglutide and obesity: a review of the data so farDrug design, development and therapy, 2015-01, Vol.9 (default), p.1867-1875 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Ladenheim. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S58459 ;PMID: 25848222Full text available |
|
12 |
Material Type: Article
|
Development and use of sulodexide in vascular diseases: implications for treatmentDrug design, development and therapy, 2013-12, Vol.8 (default), p.49-65 [Peer Reviewed Journal]COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Coccheri and Mannello. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S6762 ;PMID: 24391440Full text available |
|
13 |
Material Type: Article
|
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive surveyDrug design, development and therapy, 2011, Vol.5 (default), p.325-380 [Peer Reviewed Journal]2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Kones, publisher and licensee Dove Medical Press Ltd. 2011 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s14934 ;PMID: 21792295Full text available |
|
14 |
Material Type: Article
|
Systematic review and meta-analysis of randomized controlled trials on Wenxin keliDrug design, development and therapy, 2016-01, Vol.10, p.3725-3736 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Wang et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S112333 ;PMID: 27881911Full text available |
|
15 |
Material Type: Article
|
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid ProfileDrug design, development and therapy, 2020-01, Vol.14, p.5515-5520 [Peer Reviewed Journal]2020 Squillace et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Squillace et al. 2020 Squillace et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s274307 ;PMID: 33364747Full text available |
|
16 |
Material Type: Article
|
Pleiotropic Effects of Ticagrelor: Influence on CYP4F2 Gene and Protein Expression in HUVEC and HepG2, and Escherichia coli Bacterial SurvivalDrug design, development and therapy, 2022-08, Vol.16, p.2559-2568 [Peer Reviewed Journal]COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Meskauskaite et al. 2022 Meskauskaite et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S357985 ;PMID: 35959420Full text available |
|
17 |
Material Type: Article
|
Protective Effect Of Vasicine Against Myocardial Infarction In Rats Via Modulation Of Oxidative Stress, Inflammation, And The PI3K/Akt PathwayDrug design, development and therapy, 2019-01, Vol.13, p.3773-3784 [Peer Reviewed Journal]2019 Jiang et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Jiang et al. 2019 Jiang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S220396 ;PMID: 31802850Full text available |
|
18 |
Material Type: Article
|
The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and ExperimentDrug design, development and therapy, 2021-01, Vol.15, p.4053-4069 [Peer Reviewed Journal]2021 Zhang et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Zhang et al. 2021 Zhang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S326024 ;PMID: 34611395Full text available |
|
19 |
Material Type: Article
|
Isoborneol Attenuates Low-Density Lipoprotein Accumulation and Foam Cell Formation in MacrophagesDrug design, development and therapy, 2020, Vol.14, p.167-173 [Peer Reviewed Journal]2020 Wang et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Wang et al. 2020 Wang et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S233013 ;PMID: 32021101Full text available |
|
20 |
Material Type: Article
|
Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathwayDrug design, development and therapy, 2015-01, Vol.9 (default), p.3217-3229 [Peer Reviewed Journal]COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Al-Rasheed et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S86431 ;PMID: 26150695Full text available |